Optro recombinant human hemoglobin: SMTC plans to begin a Phase I trial

The study will test the ability of Optro to aid in hematopoiesis. Patients in the randomized, placebo-controlled, dose-ranging multicenter study will receive repeated, very low doses of the drug, and ...